October 12, 2026—Boston Scientific Corporation announced the appointment of Joseph M. Fitzgerald to Executive Vice President and Chief Operating Officer (COO), effective January 1, 2027. He will oversee the company’s global operations, business units, and regions. Fitzgerald currently serves as Executive Vice President and Group President, Cardiovascular, Boston Scientific. In conjunction with the appointment, Boston Scientific will establish th…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.